ESH International Conference Myelodysplastic Syndromes
Webcasted Presentations

Search’n Build™

Pathophysiologic links between marrow failure, genomic instability, and clona...
by Neil Young
2009-10-22 48 minutes  
Childhood MDS and JMML; biology, diagnosis, and treatment
by Henrik Hasle
2009-10-22 43 minutes    
Session 2: Diagnostic work-up of MDS6 presentations / courses
Diagnosis and WHO 2008 classification of MDS
by Anna Porwit
2009-10-22 27 minutes    
Cytogenetics and molecular genetics in MDS
by Brigitte Schlegerberger
2009-10-22 20 minutes    
Role of flow cytometry in MDS diagnostics
by Arjan Van de Loosdrecht
2009-10-22 21 minutes  
New aspects of MDS and .not yet MDS. morphology
by Barbara Bain
2009-10-22 15 minutes  
New aspects of MDS and "not yet MDS" morphology
by Barbara Bain
2009-10-22 6 minutes  
Case: Flow cytometry in myelodysplastic syndromes
by Arjan Van de Loosdrecht
2009-10-22 9 minutes    
Epidemiology
by David Bowen
2009-10-23 25 minutes    
Clinical presentation
by Martin Jädersten
2009-10-23 18 minutes    
Case
by Martin Jädersten
2009-10-23 5 minutes    
 
Chronic myelomonocytic leukaemia
by David Bowen
2009-10-23 25 minutes    
TET2 mutations in MDS and MPNs
by Michaela Fontenay
to be announced! (Waiting for speaker approval)
TET2 mutations in MDS and MPNs
by Joop Jansen
2009-10-23 16 minutes    
 
Session 5: Overlapping syndromes2 presentations / courses
Therapy related MDS
by Pierre Fenaux
2009-10-23 27 minutes    
NPM1 . rolein AML and MDS
by C. Mecucci
to be announced!
Animal models - genetically modified mice
by Rose Ann Padua
2009-10-23 23 minutes    
Somatically modified cell and animal models
by Aly Karsan
to be announced!
Treatment of 5q-; the pro-lenalidomide view
by Pierre Fenaux
2009-10-24 19 minutes    
Treatment of 5q-; the con-lenalidomide view
by Martin Jädersten
2009-10-24 15 minutes    
Session 7: Pathophysiology 5 presentations / courses
MDS research
by Jaroslaw Maciejewski
2009-10-23 38 minutes  
Apoptosis and erythroid failure in low-risk MDS
by Eva Hellstrom-Lindberg
2009-10-24 28 minutes  
Molecular biology and genetic pathways in MDS
by Jaroslaw Maciejewski
2009-10-24 34 minutes  
Molecular biology and genetic pathways in low-risk MDS
by Michaela Fontenay
2009-10-24 16 minutes  
Clonal evolution and leukaemic transformation
by S. Boehrer
2009-10-24 17 minutes    
 
Session 9: Supportive care in MDS3 presentations / courses
Treatment of transfusion iron overload in MDS; the pro-chelation view
by ROSE Christian
2009-10-24 17 minutes    
Treatment of transfusion iron overload in MDS; the con-chelation view
by David Bowen
2009-10-24 16 minutes    
Management and treatment of thrombocytopenia
by Guillermo Garcia Manero
2009-10-24 31 minutes    
 
Session 10: Curative treatment4 presentations / courses
Ablative SCT ± preceding chemotherapy
by Theo De Witte
2009-10-24 26 minutes  
Non myelomablative stem cell transplantation
by Nicolaus Kröger
2009-10-24 22 minutes  
Treatment of paediatric MDS
by Henrik Hasle
to be announced!
Case
by Theo De Witte
to be announced!
Session 11: Treatment of low-risk MDS2 presentations / courses
Growth factor treatment of low-risk MDS
by Eva Hellstrom-Lindberg
2009-10-25 22 minutes  
Immunosupression in low-risk MDS
by Neil Young
2009-10-25 18 minutes  
Azacytidine in MDS
by Pierre Fenaux
2009-10-25 24 minutes    
Decitabine in MDS
by Michael Lubbert
2009-10-25 16 minutes  
High-risk MDS: HIDACi and ongoing trials at clinical trials.gov
by Guillermo Garcia Manero
2009-10-25 33 minutes